MavenVue's software provides business and "medical intelligence" to life science professionals by uncovering relationships between diseases, genes, chemicals, drugs, trials, therapeutics and organizations across a database of over 200 million records. Our mission is to help you make better-informed decisions about where to direct your time, money, and attention.

For the past several years, we have been working closely with leading research hospitals to build a software tool to answer questions that inform their executive decisions relevant to their investment strategy, licensing and commercialization of their intellectual property, how to allocate their research dollars and to track their competition in order to remain leaders in medical breakthroughs.

MavenVue reveals the technologies your competitors are actively pursuing and how far along they are in the innovation process. We give you the ability to follow the money, by showing the top commercial and academic organizations that are receiving funding or investing in a technology area. We also show which organizations are leading research, clinical trials, and protecting intellectual property within a technology area. By tracking competitive activity over time, MavenVue sheds light on the potential threats that lie ahead, helping you make informed decisions on which opportunities you should pursue.

MavenVue brings the latest innovations from commercial, academic and government research organizations around the world to you in a few clicks. We show you the experts and the organizations receiving funding, leading research, publishing, patenting and sponsoring clinical trials in a specific technology or therapeutic space to inform your decisions around investments, licensing, acquisitions and research spend.

MavenVue's initial focus is helping health and life science organizations make informed decisions that drive innovation in healthcare by connecting the dots between technologies, diseases, and the organizations working or investing in those technologies. We give our users the ability to see how technologies are being applied in medicine by showing relationships amongst genes, chemicals, FDA approved drugs, therapeutic targets, and organizations working in related spaces allowing users to quickly identify potential competitors or collaboration partners.

We want to help inventors monetize and commercialize their  IP by giving them prior art searching capabilities and insight into potential partners or investors.  Our software helps organizations and investors find IP assets, inventors and start-ups looking for partners or cash.

Innovation can come from anywhere, including technologies borrowed from distinctly different fields or unrelated applications. MavenVue reveals non-obvious relationships amongst research, patents, or therapeutics that may not be directly related to an existing technology, but could prove to be an incremental improvement or transformative.